MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/jc.2014-2035

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2014

Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.

Balti Eric V, Vandemeulebroucke Evy, Weets Ilse, Van De Velde Ursule, Van Dalem Annelien, Demeester Simke, Verhaeghen Katrijn, Gillard Pieter, De Block Christophe, Ruige Johannes, Keymeulen Bart, Pipeleers Daniel G, Decochez Katelijn, Gorus Frans K, Belgian Diabetes Registry

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

CONTEXT AND

OBJECTIVE

In preparation of future prevention trials, we aimed to identify predictors of 3-year diabetes onset among oral glucose tolerance test (OGTT)- and hyperglycemic clamp-derived metabolic markers in persistently islet autoantibody positive (autoAb(+)) offspring and siblings of patients with type 1 diabetes (T1D).

DESIGN

The design is a registry-based study.

SETTING

Functional tests were performed in a hospital setting.

PARTICIPANTS

Persistently autoAb(+) first-degree relatives of patients with T1D (n = 81; age 5-39 years).

MAIN OUTCOME MEASURES: We assessed 3-year predictive ability of OGTT- and clamp-derived markers using receiver operating characteristics (ROC) and Cox regression analysis. Area under the curve of clamp-derived first-phase C-peptide release (AUC(5-10 min); min 5-10) was determined in all relatives and second-phase release (AUC(120-150 min); min 120-150) in those aged 12-39 years (n = 62).

RESULTS

Overall, the predictive ability of AUC(5-10 min) was better than that of peak C-peptide, the best predictor among OGTT-derived parameters (ROC-AUC [95%CI]: 0.89 [0.80-0.98] vs 0.81 [0.70-0.93]). Fasting blood glucose (FBG) and AUC(5-10 min) provided the best combination of markers for prediction of diabetes within 3 years; (ROC-AUC [95%CI]: 0.92 [0.84-1.00]). In multivariate Cox regression analysis, AUC(5-10 min)) (P = .001) was the strongest independent predictor and interacted significantly with all tested OGTT-derived parameters. AUC(5-10 min) below percentile 10 of controls was associated with 50-70% progression to T1D regardless of age. Similar results were obtained for AUC(120-150 min).

CONCLUSIONS

Clamp-derived first-phase C-peptide release can be used as an efficient and simple screening strategy in persistently autoAb(+) offspring and siblings of T1D patients to predict impending diabetes.

Для цитирования: Balti Eric V, Vandemeulebroucke Evy, Weets Ilse, Van De Velde Ursule, Van Dalem Annelien, Demeester Simke, Verhaeghen Katrijn, Gillard Pieter, De Block Christophe, Ruige Johannes, Keymeulen Bart, Pipeleers Daniel G, Decochez Katelijn, Gorus Frans K, Belgian Diabetes Registry. Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.. The Journal of clinical endocrinology and metabolism. 2014. DOI: 10.1210/jc.2014-2035.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.